Cargando…
Engineering Self-Assembled Nanomedicines Composed of Clinically Approved Medicines for Enhanced Tumor Nanotherapy
The traditional nanocarriers are typically constructed to deliver anticancer agents for improving drug bioavailability and enhancing chemotherapeutic efficacy, but this strategy suffers from the critical issue of nanocarrier biosafety that hinders further clinical translation. In this work, a unique...
Autores principales: | Jiang, Quzi, Yu, Luodan, Chen, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534536/ https://www.ncbi.nlm.nih.gov/pubmed/37764528 http://dx.doi.org/10.3390/nano13182499 |
Ejemplares similares
-
Nanomedicine‐Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy
por: Zhang, Zheng, et al.
Publicado: (2022) -
Energy Conversion-Based Nanotherapy for Rheumatoid Arthritis Treatment
por: Wang, Pingping, et al.
Publicado: (2020) -
Self-assembled organic nanomedicine enables ultrastable photo-to-heat converting theranostics in the second near-infrared biowindow
por: Xiang, Huijing, et al.
Publicado: (2021) -
Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018) -
Approved Nanomedicine against Diseases
por: Jia, Yuanchao, et al.
Publicado: (2023)